Coagulation screening tests have become the part and parcel of the array of blood tests performed routinely in most hospitals. The definite indications for ordering these tests include haemorrhagic symptoms and monitoring of anticoagulant therapy [1]. However, increasingly, they are part of “routine” screening including pre-procedure checks for likelihood of bleeding during surgery or interventions. This is despite evidence that preoperative and preprocedure coagulation screening did not show any benefits since abnormal results did not predict bleeding [2].
